MANHASSET, N.Y.--(BUSINESS WIRE)--Jul 17, 2025--
Approximately 81 percent of the U.S. population received at least one dose of the COVID-19 vaccine, and now, researchers from Northwell Health’sFeinstein Institutes for Medical Research found that COVID-19 vaccine booster shots provide important protection against severe COVID-19 illness with hospitalization for people living with cancer.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250717198151/en/
The retrospective cohort study, published today in JAMA Oncology, observed over 70,000 patients across four U.S. health systems — including Northwell — and examined the effectiveness of both the monovalent (original) and bivalent (updated) COVID-19 boosters. They found that both boosters significantly reduced COVID-19 hospitalizations.
“COVID-19 vaccines can offer another layer of protection for individuals navigating cancer treatment,” said James M. Crawford, MD, PhD, professor in the Institute of Health System Sciences at the Feinstein Institutes and co-PI of the study. “This research provides critical information for doctors and patients making decisions about COVID-19 vaccination, especially for vulnerable groups.”
The study showed that the both the monovalent and bivalent boosters reduced hospitalizations for whom by nearly 30 percent. While these boosters were effective, the study also revealed a concerning trend: booster uptake among cancer patients was lower than expected, with 69 percent receiving the monovalent booster and only 38 percent receiving the bivalent booster.
“Dr. Crawford and his team’s research provides vital knowledge that could help protect the health and well-being of immunocompromised people, like those living with cancer,” said Ping Wang, MD, professor and chief scientific officer and senior vice president at the Feinstein Institutes. “This study highlights the value of vaccination, particularly for those most vulnerable to serious illnesses.”
The study also compared the effectiveness of the boosters in cancer patients to their effectiveness in people without compromised immune systems. While the percentage reduction in hospitalizations was similar between the two groups, the number of people who needed to be vaccinated to prevent a single hospitalization was much smaller for cancer patients.
About the Feinstein Institutes
The Feinstein Institutes for Medical Researchis the home of the research institutes of Northwell Health, the largest health care provider and private employer in New York State. Encompassing 50+ research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its six institutes of behavioral science, bioelectronic medicine, cancer, health system science, molecular medicine, and translational research. We are the global scientific leader in bioelectronic medicine – an innovative field of science that has the potential to revolutionize medicine. The Feinstein Institutes publishes two open-access, international peer-reviewed journalsMolecular MedicineandBioelectronic Medicine. Through theElmezzi Graduate School of Molecular Medicine, we offer an accelerated PhD program. For more information about how we produce knowledge to cure disease, visithttp://feinstein.northwell.eduand follow us onLinkedIn.
Dr. James M. Crawford was co-PI of the study. (Credit: Feinstein Institutes).
WASHINGTON (AP) — Inflation likely remained elevated last month as the cost of electricity, groceries, and clothing may have jumped and continued to pressure consumers' wallets.
The Labor Department is expected to report that consumer prices rose 2.6% in December compared with a year earlier, according to economists' estimates compiled by data provider FactSet. The yearly rate would be down from 2.7% in November. Monthly prices, however, are expected to rise 0.3% in December, faster than is consistent with the Federal Reserve's 2% inflation goal.
The figures are harder to predict this month, however, because the six-week government shutdown last fall suspended the collection of price data used to compile the inflation rate. Some economists expect the December figures will show a bigger jump in inflation as the data collection process gets back to normal.
Core prices, which exclude the volatile food and energy categories, are also expected to rise 0.3% in December from the previous month, and 2.7% from a year earlier. The yearly core figure would be an increase from 2.6% in November.
In November, annual inflation fell from 3% in September to 2.7%, in part because of quirks in November's data. (The government never calculated a yearly figure for October). Most prices were collected in the second half of November, after the government reopened, when holiday discounts kicked in, which may have biased November inflation lower.
And since rental prices weren't fully collected in October, the agency that prepares the inflation reports used placeholder estimates that may have biased prices lower, economists said.
Inflation has come down significantly from the four-decade peak of 9.1% that it reached in June 2022, but it has been stubbornly close to 3% since late 2023. The cost of necessities such as groceries is about 25% higher than it was before the pandemic, and other necessities such as rent and clothing have also gotten more expensive, fueling dissatisfaction with the economy that both President Donald Trump and former President Joe Biden have sought to address, though with limited success.
The Federal Reserve has struggled to balance its goal of fighting inflation by keeping borrowing costs high, while also supporting hiring by cutting interest rates when unemployment worsens. As long as inflation remains above its target of 2%, the Fed will likely be reluctant to cut rates much more.
The Fed reduced its key rate by a quarter-point in December, but Chair Jerome Powell, at a press conference explaining its decision, said the Fed would probably hold off on further cuts to see how the economy evolves.
The 19 members of the Fed’s interest-rate setting committee have been sharply divided for months over whether to cut its rate further, or keep it at its curent level of about 3.6% to combat inflation.
Trump, meanwhile, has harshly criticized the Fed for not cutting its key short-term rate more sharply, a move he has said would reduce mortgage rates and the government's borrowing costs for its huge debt pile. Yet the Fed doesn't directly control mortgage rates, which are set by financial markets.
In a move that cast a shadow over the ability of the Fed to fight inflation in the future, the Department of Justice served the central bank last Friday with subpoenas related to Powell's congressional testimony in June about a $2.5 billion renovation of two Fed office buildings. Trump administration officials have suggested that Powell either lied about changes to the building or altered plans in ways that are inconsistent with those approved by planning commissions.
In a blunt response, Powell said Sunday those claims were “pretexts” for an effort by the White House to assert more control over the Fed.
“The threat of criminal charges is a consequence of the Federal Reserve setting interest rates based on our best assessment of what will serve the public, rather than following the preferences of the President,” Powell said. “This is about whether the Fed will be able to continue to set interest rates based on evidence and economic conditions—or whether instead monetary policy will be directed by political pressure or intimidation.”
FILE -American Giant clothing is displayed at the company's showroom in San Francisco, April 17, 2025. (AP Photo/Jeff Chiu, File)
FILE -A cashier rings up groceries in Dallas, Aug. 28, 2025. (AP Photo/LM Otero, File)
